Market Cap

Fine Foods & Pharmaceuticals N.T.M. S.p.A. Market Capitalization:

€223.8 Million

EUR as of July 1, 2024

US$240.3 Million

business Fine Foods & Pharmaceuticals N.T.M. S.p.A. Company Profile

Fine Foods & Pharmaceuticals N.T.M. S.p.A. Main Stock Listing

MTA: FF

Market Capitalization History of Fine Foods & Pharmaceuticals N.T.M. S.p.A.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
Zoetis Inc. $80.13 B
MERCK Kommanditgesellschaft auf Aktien $71.24 B
Takeda Pharmaceutical Company Limited $41.23 B
Haleon plc $37.32 B
Teva Pharmaceutical Industries Limited $18.88 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of Fine Foods & Pharmaceuticals N.T.M. S.p.A. market cap

Date Market Cap YoY Change
Jan. 1, 2024 €214.3 M 7.71%
Jan. 1, 2023 €199.0 M -40.66%
Jan. 1, 2022 €335.4 M 29.38%
Jan. 1, 2021 €259.2 M -13.52%
Jan. 1, 2020 €299.7 M 24.49%
Jan. 1, 2019 €240.8 M -2.97%
Jan. 1, 2018 €248.1 M 3.38%
Jan. 1, 2017 €240.0 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Fine Foods & Pharmaceuticals N.T.M. S.p.A. Categories

Italy languages Healthcare languages Drug Manufacturers—Specialty & Generic
Italy Healthcare Italy Drug Manufacturers—Specialty & Generic

Stocks & Indices

Fine Foods & Pharmaceuticals N.T.M. S.p.A. has the following listings and related stock indices.


Stock: MTA: FF

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.